P&R

Enovis Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Giovedì, Febbraio 22, 2024

Wilmington, DE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023.

Key Points: 
  • Wilmington, DE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023.
  • Enovis’ fourth-quarter net sales of $455 million grew 11% from the same quarter in 2022, including 8% organic growth.
  • Fourth quarter results reflect continued execution in P&R, above-market growth in Recon, and the impact of recent acquisitions.
  • Enovis’ full year 2023 net sales of $1.7 billion grew 9% year over year, including 8% organic growth.

Enovis Announces Business Segment Leadership Transition Plan

Retrieved on: 
Martedì, Dicembre 5, 2023

Louie Vogt, president and general manager of surgical, has been promoted to Group President Reconstructive (Recon), a newly created role in which he will lead the Company’s global reconstructive business segment.

Key Points: 
  • Louie Vogt, president and general manager of surgical, has been promoted to Group President Reconstructive (Recon), a newly created role in which he will lead the Company’s global reconstructive business segment.
  • Louie has a proven track record driving double-digit growth and market outperformance in our U.S. surgical business through innovation and commercial excellence.
  • Terry has played a vital role in the return of our P&R segment to consistent growth and strong cash flow.
  • Mr. Vogt joined DJO (now Enovis) in 2017, leading the Surgical Global Product Management and US Sales Organizations before becoming President of the Enovis U.S. surgical business.

Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook

Retrieved on: 
Martedì, Novembre 7, 2023

Wilmington, DE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter ended September 29, 2023. The Company will host an investor conference call and live webcast to discuss these results today at 8:00 am ET.

Key Points: 
  • Wilmington, DE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter ended September 29, 2023.
  • The Company will host an investor conference call and live webcast to discuss these results today at 8:00 am ET.
  • Enovis’ third quarter net sales of $418 million grew 9% from the same quarter in 2022, including 6.2% organic sales per day growth.
  • Third quarter results reflect continued stability in P&R, above market growth in Recon, and the impact of recent acquisitions.

EQS-News: SCHIRP & PARTNER Rechtsanwälte mbB: P&R: Insolvency administrator Jaffé announces what payoffs investors can expext. Fidera limits its purchase offer

Retrieved on: 
Venerdì, Giugno 16, 2023

SCHIRP & PARTNER Rechtsanwälte mbB: P&R: Insolvency administrator Jaffé announces what payoffs investors can expext.

Key Points: 
  • SCHIRP & PARTNER Rechtsanwälte mbB: P&R: Insolvency administrator Jaffé announces what payoffs investors can expext.
  • P&R: Insolvency administrator Jaffé announces for the first time what payouts investors can expect from the insolvency.
  • International fund Fidera limits its purchase offer for insolvency claims until 30 September.
  • P&R insolvency administrator Jaffé has for the first time given an estimate of what insolvency payouts investors can expect.

Stellus Capital Management, LLC Provides Unitranche Financing to Support the Acquisition of Pink Buckle and Ruby Buckle by Equine Network, a Portfolio Company of Growth Catalyst Partners

Retrieved on: 
Mercoledì, Giugno 7, 2023

Stellus Capital Management, LLC (“Stellus”) announced today that its affiliates provided senior debt financing to support the acquisition of Pink Buckle and Ruby Buckle (“P&R”), a series of prestigious barrel racing competitions, by Equine Network, LLC (“Equine Network” or the “Company”), a portfolio company of Growth Catalyst Partners (“GCP”).

Key Points: 
  • Stellus Capital Management, LLC (“Stellus”) announced today that its affiliates provided senior debt financing to support the acquisition of Pink Buckle and Ruby Buckle (“P&R”), a series of prestigious barrel racing competitions, by Equine Network, LLC (“Equine Network” or the “Company”), a portfolio company of Growth Catalyst Partners (“GCP”).
  • With its strategic acquisitions within the equine industry, Equine Network has positioned itself as the world’s most valuable equine resource for riders and their horses.
  • The P&R acquisition fits naturally with the Equine Network’s expansive growth plans, adding a new dimension to its robust Western Sports Group offerings.
  • Scott Peters, Co-Founder and Managing Partner at GCP, said, “We appreciate Stellus’ ability to work quickly and efficiently in support of the transaction.

Cadence Introduces Allegro X AI, Accelerating PCB Design with More Than 10X Reduction in Turnaround Time

Retrieved on: 
Giovedì, Aprile 6, 2023

Cadence Design Systems, Inc. (Nasdaq: CDNS) today announced the Cadence® Allegro® X AI technology, a next-generation system design technology that offers revolutionary improvements in performance and automation.

Key Points: 
  • Cadence Design Systems, Inc. (Nasdaq: CDNS) today announced the Cadence® Allegro® X AI technology, a next-generation system design technology that offers revolutionary improvements in performance and automation.
  • The Allegro X AI technology leverages the scalability of the cloud for physical design automation, offering generative design of the PCB while ensuring the design is electrically correct and manufacturable.
  • Using the generative AI capabilities, customers can streamline their system design process achieving a 10X or more reduction in PCB design turnaround time.
  • Our team is collaborating closely with Cadence to automate the placement and routing of IC package and PCB reference designs with the Allegro X AI technology to enable an order-of-magnitude reduction in design turnaround time.”

P&R Dental Strategies Announces Rebrand to Fluent

Retrieved on: 
Mercoledì, Marzo 22, 2023

HAMILTON, N.J., March 22, 2023 /PRNewswire/ -- P&R Dental Strategies, LLC (P&R), the premier dental insights company delivering customized, actionable business intelligence to support a variety of dental stakeholder objectives, announced today that it has rebranded itself as Fluent.

Key Points: 
  • HAMILTON, N.J., March 22, 2023 /PRNewswire/ -- P&R Dental Strategies, LLC (P&R), the premier dental insights company delivering customized, actionable business intelligence to support a variety of dental stakeholder objectives, announced today that it has rebranded itself as Fluent.
  • Throughout its history, Fluent has continued to expand into new markets and innovate in its delivery of best-of-breed technology-enabled services, advanced dental analytics, and optimized end-to-end workflow solutions.
  • Fluent also recently announced the acquisitions of Dentistat® and go2dental®, industry leaders in the highly complementary dental credentialing services and member engagement tools, respectively.
  • P&R Dental Strategies will remain the legal name of the corporate entity but will now do business as Fluent.

P&R Dental Strategies Announces Acquisition of Dentistat and go2dental.com

Retrieved on: 
Mercoledì, Gennaio 18, 2023

HAMILTON, N.J., Jan. 18, 2023 /PRNewswire/ -- P&R Dental Strategies, LLC (P&R), the premier dental insights company delivering customized, actionable business intelligence to support a variety of dental stakeholder objectives, today announced the acquisition of the sister companies Dentistat, Inc. and go2dental.com, Inc.

Key Points: 
  • The acquisitions expand P&R Dental Strategies' suite of best-in-class solutions for dental payers with the premier dentist credentialing and member engagement solutions in the industry.
  • HAMILTON, N.J., Jan. 18, 2023 /PRNewswire/ -- P&R Dental Strategies, LLC (P&R), the premier dental insights company delivering customized, actionable business intelligence to support a variety of dental stakeholder objectives, today announced the acquisition of the sister companies Dentistat, Inc. and go2dental.com, Inc.
    Dentistat has been providing the industry's leading outsourced dental credentialing services for over 50 years.
  • Dentistat's highly refined credentialing process ensures thorough, efficient and reliable dental network development and retention for dental payers.
  • For more information about P&R Dental Strategies and our dental business intelligence solutions, visit https://www.pandrdental.com

P&R Dental Strategies' Data Used by the School of Dentistry at Indiana University in Pediatric Pulpal Therapy Treatment Usage Trends Study

Retrieved on: 
Martedì, Novembre 8, 2022

HAMILTON, N.J., Nov. 8, 2022 /PRNewswire/ -- P&R Dental Strategies, LLC (P&R), the premier dental insights company delivering customized, actionable business intelligence to support a variety of dental stakeholder objectives, announced today that its research partnership with the School of Dentistry at Indiana University has produced another study selected for peer-reviewed publication and co-authored by P&R's Chief Analytics Officer, Tim Downey.

Key Points: 
  • The study, which was published in the October 27, 2022 online issue of The Journal of the American Dental Association (JADA), is titled "Insurance Claim Data Trends in Pulpal Therapy for Pediatric Patients."
  • JADA is the nation's premier dental journal and has previously featured two other IU/P&R collaborative articles.
  • The study identifies differences in usage trends for two specific pulpal therapy treatments in pediatric patients during an 11-year period from January 1, 2010 through December 31, 2020.
  • P&R Dental Strategies customers can depend on the support of an industry-leading team of dentists, consultants and statisticians to focus on their unique challenges.

P&R Dental Strategies Partners with Dominion National to Integrate DentaQual® Dentist Quality & Performance Rating System into Dominion's Online Member Directory

Retrieved on: 
Martedì, Settembre 20, 2022

HAMILTON, N.J. , Sept. 20, 2022 /PRNewswire/ -- P&R Dental Strategies, LLC (P&R) the dental industry's source for data-driven business intelligence and performance measurement solutions, today announced a partnership with Dominion National, a leading insurer and administrator of dental and vision benefits to include DentaQual ratings in Dominion's online dentist directory. Dominion National plan members will now see star ratings linked to a provider score card as they search for an in-network dental provider. This partnership helps meet the growing need for transparency in provider information and will help to empower Dominion's members to make informed healthcare decisions.

Key Points: 
  • Dominion National plan members will now see star ratings linked to a provider score card as they search for an in-network dental provider.
  • DentaQual is the first-ever truly objective dental performance rating system.
  • As interest for objective performance scores grows among dental patients, employers, and insurance payers, DentaQual provides independent third-party data-driven information for these groups.
  • P&R Dental Strategies customers can depend on the support of an industry-leading team of dentists, consultants and statisticians to focus on their unique challenges.